je.st
news
Tag: cancer
BlackBerry Wants to Help Cure Cancer
2015-01-07 22:02:45| PC Magazine Cell Phones Product Guide
At CES, BlackBerry showed off the HBox, which can help your doctor monitor your health.
Tags: cancer
cure
blackberry
Cervical Cancer Awareness Month
2015-01-05 08:16:26| Biotech - Topix.net
According to the Centers for Disease Control and Prevention , over 12,000 women are diagnosed with cervical cancer, and over 4,000 lose the battle with this disease. Dr. Santhosh Ambika practices hematology and oncology within the Hahn Cancer Center at Sentara RMH.
Tags: month
cancer
awareness
cervical
Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research
2014-12-31 17:46:02| Biotech - Topix.net
Aeterna Zentaris Inc. today announced that an article on final data for the Phase 1 portion of the ongoing Phase 1/2 trial in prostate cancer with zoptarelin doxorubicin , a hybrid molecule composed of a synthetic peptide carrier and a well-known chemotherapy agent, doxorubicin, has been published in the December issue of Clinical Cancer Research . The article outlines data previously disclosed in June 2013 at the American Society of Clinical Oncology's Annual Meeting, which demonstrated the compound's safety profile and promising anti-tumor activity in heavily pretreated men with castration- and taxane-resistant prostate cancer.
Tags: data
research
final
published
Final Phase 1 data of zoptarelin doxorubicin Phase 1/2 trial published in Clinical Cancer Research
2014-12-31 15:50:06| Logistics - Topix.net
Aeterna Zentaris Inc. today announced that an article on final data for the Phase 1 portion of the ongoing Phase 1/2 trial in prostate cancer with zoptarelin doxorubicin , a hybrid molecule composed of a synthetic peptide carrier and a well-known chemotherapy agent, doxorubicin, has been published in the December issue of Clinical Cancer Research . The article outlines data previously disclosed in June 2013 at the American Society of Clinical Oncology's Annual Meeting, which demonstrated the compound's safety profile and promising anti-tumor activity in heavily pretreated men with castration- and taxane-resistant prostate cancer.
Tags: data
research
final
published
Teva to return rights to experimental cancer therapy
2014-12-30 17:21:14| Biotech - Topix.net
Teva Pharmaceutical Industries Ltd. is returning to OncoGenex the rights to a cancer drug, on which the companies had previously collaborated. Under the terms of an initial agreement, Teva will make a $27 million to OncoGenex of Bothell, Wash.
Tags: rights
return
cancer
experimental
Sites : [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] next »